SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : TXB -Texas Biotechnology -- Ignore unavailable to you. Want to Upgrade?


To: Marshall who wrote (17)4/24/1998 1:17:00 PM
From: tom jones  Read Replies (1) | Respond to of 19
 
Nightly Business Report April 17, 1998
ALAN ACKERMAN, SENIOR VICE PRESIDENT, FAHNESTOCK & COMPANY
ACKERMAN: The other stock is Texas Biotech (AMEX:TXB). It's a stock that could have three events between May and June. It's a $16 targeted stock. At Lehman Brothers the stock is at 6 1/2. I'd look for an announcement on Novastan from the FDA, which is their cardiovascular drug within a very short period of time.